Axmed, a Swiss HealthTech company, today announced it has been awarded €5 million ($6 million) in non-dilutive grant funding from…
Read More
How the Critical Medicines Act Aims to Optimize European Pharma Competitiveness and Resilience
In a three-part interview (view those videos here, here, and here) conducted as part of Pharmaceutical Technology® Group’s CPHI Frankfurt…
Read More
Europe is putting vital medicines at risk by allowing ‘carbon heavy’ imports from the Far East: INEOS
INEOS has announced that its production of BDO at Marl in Germany, vital for the production of essential pharmaceutical products,…
Read More
Securing Medicines and Safeguarding Innovation
Navigating Tariffs: Securing Medicines and Safeguarding Innovation September 21, 2025 | Sunday | Views | By Lakshmy Ramakrishnan, Associate Fellow…
Read More
Sanofi to purchase Blueprint Medicines for over $9 billion | Business
As part of a strategy to strengthen its immunology segment through acquisitions, Sanofi has agreed to purchase US-based Blueprint Medicines…
Read More
Can Medicines Reach You as Fast as Groceries? DocPharma Says Yes.
India has mastered speed in everyday essentials—groceries arrive in 10 minutes, meals in under 30. Yet, when it comes to…
Read More
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
The company will file the NDA for BRIMOCHOL™ PF, a once-a-day eye drop for the treatment of presbyopia, with a…
Read More
Sanofi to acquire Blueprint Medicines
Blueprint’s most recently approved drug is Ayvakit, which the US Food and Drug Administration approved in 2020 to treat gastrointestinal…
Read More
